NCT01559454View on ClinicalTrials.gov

Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Low Back Pain
Interventions
DRUG

Methadone

10-60 mg/day divided by 2-4 times a day for 6 months

DRUG

Buprenorphine/naloxone

4-16 mg/day divided by 2-4 times a day for 6 months

Trial Locations (1)

14228

UB/MD Family Medicine, Inc., Amherst

All Listed Sponsors
lead

State University of New York at Buffalo

OTHER

NCT01559454 - Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients | Biotech Hunter | Biotech Hunter